Sandra S. Ring

880 total citations
8 papers, 220 citations indexed

About

Sandra S. Ring is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sandra S. Ring has authored 8 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Sandra S. Ring's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Sandra S. Ring is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Sandra S. Ring collaborates with scholars based in Switzerland, Germany and Austria. Sandra S. Ring's co-authors include Lukas Flatz, Angelina De Martin, Lucas Onder, Burkhard Ludewig, Mechthild Lütge, Hung‐Wei Cheng, Julia Colston, Omar Hasan Ali, Christian Perez‐Shibayama and Wolfram Jochum and has published in prestigious journals such as Nature Communications, Nature Immunology and Journal of the American Academy of Dermatology.

In The Last Decade

Sandra S. Ring

8 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra S. Ring Switzerland 6 117 107 54 28 16 8 220
Irene Mattiola Germany 8 161 1.4× 58 0.5× 77 1.4× 21 0.8× 12 0.8× 9 248
Jessica S.W. Borgers Netherlands 8 110 0.9× 115 1.1× 44 0.8× 18 0.6× 6 0.4× 13 197
Tyler G. Searles United States 5 148 1.3× 169 1.6× 53 1.0× 31 1.1× 7 0.4× 7 235
Yinan Dong China 7 131 1.1× 190 1.8× 95 1.8× 54 1.9× 11 0.7× 12 324
Lloyd Bod United States 4 130 1.1× 99 0.9× 40 0.7× 17 0.6× 8 0.5× 6 189
Jolien Ceusters Belgium 7 161 1.4× 109 1.0× 67 1.2× 17 0.6× 9 0.6× 19 248
Luisa Gazzurelli Italy 7 103 0.9× 40 0.4× 42 0.8× 15 0.5× 7 0.4× 11 154
Masako Minami‐Hori Japan 8 73 0.6× 61 0.6× 39 0.7× 14 0.5× 20 1.3× 18 277
Laura Boullerot France 9 162 1.4× 143 1.3× 80 1.5× 32 1.1× 6 0.4× 17 260
Ángela Fernández de Lascoiti Spain 4 125 1.1× 177 1.7× 31 0.6× 41 1.5× 5 0.3× 6 222

Countries citing papers authored by Sandra S. Ring

Since Specialization
Citations

This map shows the geographic impact of Sandra S. Ring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra S. Ring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra S. Ring more than expected).

Fields of papers citing papers by Sandra S. Ring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra S. Ring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra S. Ring. The network helps show where Sandra S. Ring may publish in the future.

Co-authorship network of co-authors of Sandra S. Ring

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra S. Ring. A scholar is included among the top collaborators of Sandra S. Ring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra S. Ring. Sandra S. Ring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ring, Sandra S., Jovana Cupovic, Lucas Onder, et al.. (2021). Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment. Nature Communications. 12(1). 4734–4734. 21 indexed citations
2.
Cupovic, Jovana, Sandra S. Ring, Lucas Onder, et al.. (2021). Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8+ T cells. Nature Immunology. 22(8). 1042–1051. 36 indexed citations
3.
Perez‐Shibayama, Christian, Ulrika Islander, Mechthild Lütge, et al.. (2020). Type I interferon signaling in fibroblastic reticular cells prevents exhaustive activation of antiviral CD8 + T cells. Science Immunology. 5(51). 46 indexed citations
4.
Ring, Sandra S., Erika Schmidt, Omar Hasan Ali, et al.. (2020). Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses. Molecular Therapy — Oncolytics. 19. 179–187. 5 indexed citations
5.
Ali, Omar Hasan, Andrey A. Yurchenko, Olga Pavlova, et al.. (2020). Genomic profiling of late‐onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome. Journal of the European Academy of Dermatology and Venereology. 35(2). 396–402. 2 indexed citations
6.
Hoffmann, Friederike, Romina Zarbl, Dennis Niebel, et al.. (2020). Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma. Clinical Epigenetics. 12(1). 94–94. 28 indexed citations
7.
Ali, Omar Hasan, Fiamma Berner, Christoph Ackermann, et al.. (2020). Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients. Cancer Immunology Immunotherapy. 70(2). 563–568. 6 indexed citations
8.
Ali, Omar Hasan, David Bomze, Sandra S. Ring, et al.. (2019). BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. Journal of the American Academy of Dermatology. 82(4). 854–861. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026